Precigen (PGEN) Current Leases (2012 - 2026)
Precigen (PGEN) reported Current Leases of $1.1 million for Q1 2026, up 15.09% year-over-year from $928000.0 in Q1 2025, and down 5.99% quarter-over-quarter from $1.1 million in Q4 2025.
Precigen (PGEN) Current Leases (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 10 years of Current Leases data on file, last reported at $1.1 million in Q1 2026.
- Current Leases for Q1 2026 came in at $1.1 million, up 15.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 million (up 15.09% YoY), and the FY2025 annual result was $1.1 million, up 18.83% from the prior year.
- Current Leases slipped to $1.1 million in Q1 2026 per PGEN's latest filing, from $1.1 million in the prior quarter.
- Over five years, Current Leases peaked at $1.6 million in Q1 2022 and troughed at $928000.0 in Q1 2025.
- A 5-year average of $1.2 million and a median of $1.1 million in 2025 frame the typical range for Current Leases.
- The sharpest annual moves came in 2022 and 2023: Current Leases sank 46.86% in 2022, then surged 37.56% in 2023.
- A 5-year view of Current Leases shows it stood at $1.2 million in 2022, then declined by 0.58% to $1.2 million in 2023, then declined by 20.47% to $956000.0 in 2024, then climbed by 18.83% to $1.1 million in 2025, then slipped by 5.99% to $1.1 million in 2026.
- Business Quant data shows PGEN's Current Leases at $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $1.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 42,980.09 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Precigen | 1.27 Bn | 1.27 Bn | 20.69 Mn | 1.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.07 Mn |
| Dec 31, 2025 | 1.14 Mn |
| Sep 30, 2025 | 1.12 Mn |
| Jun 30, 2025 | 930,000.00 |
| Mar 31, 2025 | 928,000.00 |
| Dec 31, 2024 | 956,000.00 |
| Sep 30, 2024 | 988,000.00 |
| Jun 30, 2024 | 1.27 Mn |
| Mar 31, 2024 | 1.32 Mn |
| Dec 31, 2023 | 1.20 Mn |
| Sep 30, 2023 | 1.20 Mn |
| Jun 30, 2023 | 1.42 Mn |
| Mar 31, 2023 | 1.24 Mn |
| Dec 31, 2022 | 1.21 Mn |
| Sep 30, 2022 | 1.04 Mn |
| Jun 30, 2022 | 1.03 Mn |
| Mar 31, 2022 | 1.59 Mn |
| Dec 31, 2021 | 1.39 Mn |
| Sep 30, 2021 | 1.96 Mn |
| Jun 30, 2021 | 1.94 Mn |